These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4682924)

  • 21. Dose-dependence of the apparent half-life of phenytoin in the rat.
    Vicuna A; Lalka D; duSouich P; Vicuna N; Ludden TM; McLean AJ
    Res Commun Chem Pathol Pharmacol; 1980 Apr; 28(1):3-11. PubMed ID: 7394315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of 5-(3,4-dihydroxyphenyl)-5-phenylhydantoin as a metabolite of 5,5-diphenylhydantoin (phenytoin) in rats and man.
    Borgå O; Garle M; Gutová M
    Pharmacology; 1972; 7(3):129-37. PubMed ID: 5054584
    [No Abstract]   [Full Text] [Related]  

  • 23. Phenytoin kinetics in children.
    Curless RG; Walson PD; Carter DE
    Neurology; 1976 Aug; 26(8):715-20. PubMed ID: 945868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on dexamethasone metabolism in man: effect of diphenylhydantoin.
    Haque N; Thrasher K; Werk EE; Knowles HC; Sholiton LJ
    J Clin Endocrinol Metab; 1972 Jan; 34(1):44-50. PubMed ID: 5008232
    [No Abstract]   [Full Text] [Related]  

  • 25. Biliary excretion of diphenylhydantoin in the rat. Time-course studies.
    Inaba T; Umeda T
    Drug Metab Dispos; 1975; 3(2):69-73. PubMed ID: 236160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical pharmacokinetics of phenytoin in the dog: a reevaluation.
    Frey HH; Löscher W
    Am J Vet Res; 1980 Oct; 41(10):1635-8. PubMed ID: 6784613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapy service and pharmacokinetics of phenytoin].
    Walther H; Meyer FP
    Padiatr Grenzgeb; 1978; 17(2):69-81. PubMed ID: 673428
    [No Abstract]   [Full Text] [Related]  

  • 28. Diphenylhydantoin metabolism. A prospective review.
    Glazko AJ
    Drug Metab Dispos; 1973; 1(5):711-4. PubMed ID: 4149711
    [No Abstract]   [Full Text] [Related]  

  • 29. The interaction of flurazepam with diphenylhydantoin in the rat.
    Sikic BI; Baumel IP
    Drug Metab Dispos; 1976; 4(6):584-6. PubMed ID: 11981
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of pregnancy on the metabolism of [14C]phenytoin in the isolated perfused rat liver.
    Vore M; Bauer J; Pascucci V
    J Pharmacol Exp Ther; 1978 Aug; 206(2):439-47. PubMed ID: 682124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased capacity to metabolize diphenylhydantoin in a patient with hypersensitivity to warfarin.
    Bochner F; Hooper WD; Eadie MJ; Tyrer JH
    Aust N Z J Med; 1975 Oct; 5(5):462-6. PubMed ID: 1061551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new model for the study of transport of [14C]-diphenylhydantoin through the gingival crevicular tissues in the rabbit.
    Steinberg AD; Allen P; Jeffay H
    Arch Oral Biol; 1975 Dec; 20(12):865-9. PubMed ID: 1066103
    [No Abstract]   [Full Text] [Related]  

  • 33. Genetic differences in phenytoin pharmacokinetics. In vivo clearance and in vitro metabolism among inbred strains of mice.
    Atlas SA; Zweier JL; Nebert DW
    Dev Pharmacol Ther; 1980; 1(5):281-304. PubMed ID: 7438974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of diphenylhydantoin on cortisol kinetics in humans.
    Choi Y; Thrasher K; Werk EE; Sholiton LJ; Olinger C
    J Pharmacol Exp Ther; 1971 Jan; 176(1):27-34. PubMed ID: 4936459
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of diphenylhydantoin on the metabolism of dicoumarol in man.
    Hansen JM; Siersbaek-Nielsen K; Kristensen M; Skovsted L; Christensen LK
    Acta Med Scand; 1971; 189(1-2):15-9. PubMed ID: 4107730
    [No Abstract]   [Full Text] [Related]  

  • 36. Conjugation-deconjugation cycling of diflunisal via beta-glucuronidase catalyzed hydrolysis of its acyl glucuronide in the rat.
    Brunelle FM; Verbeeck RK
    Life Sci; 1997; 60(22):2013-21. PubMed ID: 9180355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioavailability and single-dose pharmacokinetics of intramuscular phenytoin.
    Kostenbauder HB; Rapp RP; McGovren JP; Foster TS; Perrier DG; Blacker HM; Hulon WC; Kinkel AW
    Clin Pharmacol Ther; 1975 Oct; 18(4):449-56. PubMed ID: 1100308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of pregnancy on the pharmacokinetics of phenytoin in rats.
    Chou RC; Levy G
    J Pharmacol Exp Ther; 1984 May; 229(2):351-8. PubMed ID: 6716263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding of 5,5-diphenylhydantoin and its major metabolite to human and rat plasma proteins.
    Conard GJ; Haavik CO; Finger KF
    J Pharm Sci; 1971 Nov; 60(11):1642-6. PubMed ID: 4943934
    [No Abstract]   [Full Text] [Related]  

  • 40. Oral phenytoin in infancy: dose requirement, absorption, and elimination.
    Albani M; Wernicke I
    Pediatr Pharmacol (New York); 1983; 3(3-4):229-36. PubMed ID: 6677874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.